| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |